Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 1
1995 1
2002 3
2003 3
2004 5
2005 12
2006 12
2007 11
2008 10
2009 9
2010 7
2011 6
2012 7
2013 20
2014 10
2015 8
2016 9
2017 15
2018 7
2019 10
2020 12
2021 23
2022 28
2023 15
2024 16
2025 25
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean brody a[au] (694 results)?
Therapy of early breast cancer: current status and perspectives.
Tauber N, Amann N, Dannehl D, Deutsch TM, Dimpfl M, Fasching P, Hartkopf A, Heublein S, Hilmer L, Hörner M, Krawczyk N, Krückel A, Krug D, Marmé F, Michel LL, Reinisch M, Rody A, Schäffler H, Schneeweiss A, Utz D, Veselinovic K, Banys-Paluchowski M. Tauber N, et al. Among authors: rody a. Arch Gynecol Obstet. 2025 Aug;312(2):311-328. doi: 10.1007/s00404-025-08028-0. Epub 2025 Apr 22. Arch Gynecol Obstet. 2025. PMID: 40261372 Free PMC article. Review.
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025.
Park-Simon TW, Müller V, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, Blohmer JU, Budach W, Dall P, Ditsch N, Fallenberg EM, Fasching PA, Fehm T, Friedrich M, Gerber B, Gluz O, Harbeck N, Hartkopf AD, Heil J, Hörner-Rieber J, Huober J, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Reimer T, Reinisch M, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Tina van Mackelenbergh M, Witzel I, Wöckel A, Wuerstlein R, Janni W, Thill M. Park-Simon TW, et al. Among authors: rody a. Breast Care (Basel). 2025 Jun;20(3):189-207. doi: 10.1159/000545019. Epub 2025 Mar 8. Breast Care (Basel). 2025. PMID: 40236659 Free PMC article. Review.
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial.
Hörner M, Tretschock LM, John N, Ziegler P, Häberle L, Uhrig S, Goossens C, Amann N, Cieslik JP, Dannehl D, Deutsch TM, Dimpfl M, Ehlert M, Eichstädt K, Englisch A, Köpke MB, Krückel A, Link T, Müller A, Reinhardt K, Roth J, Schäffler H, Sych L, Tegeler CM, Wichmann C, Banys-Paluchowski M, Princk H, Rody A, Brucker SY, Ditsch N, Ettl J, Fehm T, Hack CC, Hadji P, Hein A, Janni WW, Kolberg HC, Lüftner D, Lux MP, Müller V, Schneeweiss A, Taran FA, Tesch H, Wallwiener D, Marmé F, Seitz S, Belleville E, Hartkopf A, Michel LL, Wallwiener M, Fasching PA, Tauber N. Hörner M, et al. Among authors: rody a. Breast Cancer Res Treat. 2026 Apr 2;217(1):9. doi: 10.1007/s10549-026-07939-z. Breast Cancer Res Treat. 2026. PMID: 41925922 Free PMC article.
Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer.
Zimmer P, Esser T, Lueftner D, Schuetz F, Baumann FT, Rody A, Schneeweiss A, Hartkopf AD, Decker T, Uleer C, Stoetzer OJ, Foerster F, Schmidt M, Mundhenke C, Steindorf K, Tesch H, Jackisch C, Fischer T, Hanson S, Kreuzeder J, Guderian G, Fasching PA, Bloch W. Zimmer P, et al. Among authors: rody a. BMC Med. 2024 Oct 8;22(1):442. doi: 10.1186/s12916-024-03671-x. BMC Med. 2024. PMID: 39379960 Free PMC article.
Perinatal Antibiotic Exposure and Respiratory Outcomes in Children Born Preterm.
Fortmann I, Welp A, Hoffmann N, Faust K, Silwedel C, Retzmann J, Gembicki M, Köstlin-Gille N, Häfke A, Zemlin M, Marissen J, Bossung V, Soler Wenglein J, Scharf JL, Weichert J, Müller A, Ricklefs I, Rody A, Pirr S, Boutin S, Rupp J, Brinkmann F, Heideking M, Stichtenoth G, Göpel W, Herting E, Hanke K, Härtel C. Fortmann I, et al. Among authors: rody a. JAMA Netw Open. 2025 May 1;8(5):e259647. doi: 10.1001/jamanetworkopen.2025.9647. JAMA Netw Open. 2025. PMID: 40354053 Free PMC article.
Axillary surgery in early breast cancer: real-world analysis of the INSEMA-trial at three certified university breast cancer centers in Germany regarding the omission of sentinel lymph node biopsy.
Tauber N, Rambow AC, Gasthaus C, Fick F, Grande-Nagel I, Hilmer L, Kohls F, Krawczyk N, Le HD, Elessawy M, Maass N, Müller V, Rody A, Schäfer KWF, Schmalfeldt B, Steinhilper L, Banys-Paluchowski M, van Mackelenbergh MT. Tauber N, et al. Among authors: rody a. Eur J Surg Oncol. 2025 Oct;51(10):110392. doi: 10.1016/j.ejso.2025.110392. Epub 2025 Aug 14. Eur J Surg Oncol. 2025. PMID: 40834690 Free article.
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.
Banys-Paluchowski M, Hartmann S, de Boniface J, Gentilini OD, Ditsch N, Stickeler E, Karadeniz Cakmak G, Hauptmann M, Schroth J, Thill M, di Micco R, Hahn M, Murawa D, Rubio IT, Pinto D, Kontos M, Niinikoski L, Gasparri ML, Nina H, Rebaza LP, Fröhlich S, Schmidt E, Wihlfahrt K, Berger T, Basali T, Ruf F, Rief A, Bonci EA, Peintinger F, Schlichting E, Valiyeva Qanimat H, Vanhoeij M, Kadayaprath G, Dostalek L, Kothari A, Perhavec A, Ivanov T, Zippel D, Adamczyk B, Porpiglia M, Gürleyik GM, Untch M, Lux MP, Jursik K, Kolberg HC, Reimer T, Tauber N, Rody A, Matrai Z, Krawczyk N, Thongvitokomarn S, Kühn T. Banys-Paluchowski M, et al. Among authors: rody a. J Clin Oncol. 2026 Mar;44(7):575-585. doi: 10.1200/JCO-25-01921. Epub 2026 Jan 21. J Clin Oncol. 2026. PMID: 41564379
Clinical use of GnRH analogues.
Kiesel LA, Rody A, Greb RR, Szilágyi A. Kiesel LA, et al. Among authors: rody a. Clin Endocrinol (Oxf). 2002 Jun;56(6):677-87. doi: 10.1046/j.1365-2265.2002.01291.x. Clin Endocrinol (Oxf). 2002. PMID: 12072036 Review. No abstract available.
HER2-Positive Early Breast Cancer: Time for Ultimate De-Escalation?
Tauber N, Cirkel C, Claussen A, Fick F, Kontomanolis E, Krawczyk N, Rody A, Banys-Paluchowski M. Tauber N, et al. Among authors: rody a. Cancers (Basel). 2024 Mar 11;16(6):1121. doi: 10.3390/cancers16061121. Cancers (Basel). 2024. PMID: 38539456 Free PMC article. Review.
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Sütterlin MW, Ruebner M, Theuser AK, Hofmann NM, Böhm S, Almstedt K, Kellner S, Gass P, Lück HJ, Hein A, Schmatloch S, Kalder M, Uleer C, Juhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Huebner H, Goossens C, Brucker SY, Hack CC, Fehm TN, Fasching PA. Beierlein M, et al. Among authors: rody a. Int J Cancer. 2025 Dec 1;157(11):2363-2373. doi: 10.1002/ijc.70037. Epub 2025 Jul 11. Int J Cancer. 2025. PMID: 40641449 Free PMC article. Clinical Trial.
265 results